Back to Search
Start Over
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force.
- Source :
- Journal of Translational Medicine; 2010, Vol. 8, p130-138, 9p
- Publication Year :
- 2010
-
Abstract
- The International Society for Biological Therapy of Cancer (iSBTc, recently renamed the Society for Immunotherapy of Cancer, SITC) hosted a one-day symposium at the National Institutes of Health on September 30, 2010 to address development and application of biomarkers in cancer immunotherapy. The symposium, titled Immuno-Oncology Biomarkers 2010 and Beyond: Perspectives from the iSBTc/SITC Biomarker Task Force, gathered approximately 230 investigators equally from academia, industry and governmental/regulatory agencies from around the globe for panel discussions and presentations on the following topics: 1) immunologic monitoring: standardization and validation of assays; 2) correlation of immunity to biologic activity, clinical response and potency assays; 3) novel methodologies for assessing the immune landscape: clinical utility of novel technologies; and 4) recommendations on incorporation of biomarkers into the clinical arena. The presentations are summarized in this report; additional program information and slides are available online at the iSBTc/SITC website. [ABSTRACT FROM AUTHOR]
- Subjects :
- CONFERENCES & conventions
BIOMARKERS
CANCER immunotherapy
IMMUNITY
Subjects
Details
- Language :
- English
- ISSN :
- 14795876
- Volume :
- 8
- Database :
- Complementary Index
- Journal :
- Journal of Translational Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 57249232
- Full Text :
- https://doi.org/10.1186/1479-5876-8-130